Live Well ft. Lance Alexander

NUH launches Singapore's first prawn allergy oral immunotherapy clinical trial

23 min Listen to the original Episode page
HealthcareClinical TrialsAllergiesMedical TechnologySingapore Health

Summary

The episode discusses the rising prevalence of prawn allergies in Singapore, affecting an estimated 90,000 to 150,000 people. Professor Andreas Lopata from NUH explains that these allergies often develop in adulthood rather than at birth. NUH has announced a five-year clinical trial funded by NIF and NHMRC to test oral immunotherapy using standardized prawn powder. The trial aims to enroll 50 patients and expects results by the end of 2027. The discussion also covers diagnostic technologies like the macro array and future AI integration for allergen analysis.

Key takeaways

  1. 1
    Shellfish allergy affects an estimated 90,000 to 150,000 people in Singapore.

    Unidentified speaker (speaker_1) · 0:05

  2. 2
    NUH announced Singapore's first clinical trial of oral immunotherapy for prawn allergy.

    Unidentified speaker (speaker_1) · 0:45

Episode sections

  1. 0:05 – 0:45

    Introduction to Prawn Allergy Prevalence

    Shellfish allergy affects an estimated 90,000 to 150,000 people in Singapore. Prawns are a common ingredient in local dishes like soup stock and sambal, posing risks for allergic individuals.

  2. 0:45 – 1:21

    NUH Clinical Trial Announcement

    NUH announced Singapore's first clinical trial of oral immunotherapy for prawn allergy. The trial tests if gradually increasing doses of prawn powder can help patients build tolerance, with Professor Andreas Lopata joining to discuss.

  3. 1:21 – 3:57

    Onset and Symptoms of Prawn Allergy

    Prawn allergy typically develops later in life, often in adulthood, rather than being present at birth. Symptoms include itching, eczema, and potential anaphylaxis, with reactions usually occurring within 30 minutes to an hour.

  4. 3:57 – 5:01

    Cross-Reactivity and Species Differences

    Twelve different proteins in prawns are registered allergens. There are differences in allergenicity between species like tiger prawns and vanamei prawns, leading to the development of an immunotherapy targeting both.

  5. 5:01 – 10:26

    Environmental Triggers and Diagnosis

    Allergies can develop suddenly due to immune system changes. House dust mites are linked to asthma and potentially food allergies. Modern diagnostic tests like the macro array can test for hundreds of allergens via blood samples.

  6. 10:26 – 12:58

    Oral Immunotherapy Mechanism and Process

    Oral immunotherapy involves taking small amounts of standardized prawn powder daily to build protective antibodies. The process starts in a hospital setting before moving to home administration, aiming to prevent reactions to accidental exposure.

  7. 12:58 – 19:00

    Trial Status and Funding

    The trial is in early stages, funded by NIF and NHMRC for five years. It aims to enroll around 50 patients. Results are expected by the end of 2027, with full desensitization data taking 3-4 years to gather.

  8. 19:00 – 22:34

    AI Integration and Future Therapeutics

    AI is planned for later stages to analyze large datasets from mass spectrometry and protein sequencing. This platform could eventually be applied to local inhalant allergies like pollen and grass, which differ from European/US varieties.

Claims worth verifying

Shellfish allergy affects an estimated 90,000 to 150,000 people in Singapore.

Unidentified speaker (speaker_1) ·0:05

How to verify: Check Singapore Ministry of Health statistics or recent epidemiological studies on food allergies in Singapore. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

NUH announced Singapore's first clinical trial of oral immunotherapy for prawn allergy.

Unidentified speaker (speaker_1) ·0:45

How to verify: Search NUH press releases or clinical trial registries (e.g., ClinicalTrials.gov) for Singapore's first prawn allergy oral immunotherapy trial. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

Prawn allergy is not a genetic disorder and usually develops later in life, often in adulthood.

Unidentified speaker (speaker_2) ·1:31

How to verify: Review medical literature on the etiology of shellfish allergies, specifically looking for studies on adult-onset allergies versus congenital ones. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

There are twelve different proteins in prawns registered as allergens by the World Health Organization.

Unidentified speaker (speaker_2) ·3:57

How to verify: Check the World Health Organization's allergen database or scientific publications listing WHO-registered allergens. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

House dust mites are related to 50% of asthma cases.

Unidentified speaker (speaker_2) ·6:47

How to verify: Review medical studies or WHO data on the correlation between house dust mite allergies and asthma prevalence. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

The macro array technology can test for 300 allergens simultaneously, including 150 purified single components.

Unidentified speaker (speaker_2) ·7:02

How to verify: Search for publications or product specifications regarding the 'macro array' diagnostic technology developed by the researchers. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

Oral immunotherapy for peanut allergy has been successful in the US for several years.

Unidentified speaker (speaker_2) ·10:26

How to verify: Review FDA approvals or clinical trial results for peanut oral immunotherapy products (e.g., Palforzia) in the US. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

The prawn allergy trial is funded by NIF and NHMRC for five years.

Unidentified speaker (UNKNOWN) ·13:02

How to verify: Check NIF and NHMRC grant announcements or press releases regarding the specific funding amount and duration for this trial. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

The trial aims to enroll around 50 patients.

Unidentified speaker (speaker_2) ·13:11

How to verify: Review the clinical trial protocol or registration details for the number of participants required. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

Results are expected by the end of 2027, with full data taking 3-4 years.

Unidentified speaker (speaker_2) ·16:34

How to verify: Check the trial's projected timeline in clinical trial registries or future press releases from NUH/JCU. For recent events, verify 2026-08-20 through 2026-11-20. Use another period only when the speaker explicitly names it.

Do your own research

  • Verify the current status and enrollment numbers of the NUH prawn allergy oral immunotherapy trial via the NUH press releases or ClinicalTrials.gov.
  • Check the World Health Organization's allergen nomenclature database to confirm the 12 registered prawn proteins.
  • Review NIF and NHMRC funding announcements for the specific grant amounts and duration of the prawn allergy trial.
  • Compare the efficacy and safety data of existing US-approved peanut oral immunotherapy products (e.g., Palforzia) against the proposed prawn therapy methodology.
  • Investigate the commercialization potential and patent landscape for macro array diagnostic technology providers in Singapore.
  • Assess the prevalence data of shellfish allergies in Singapore against national health statistics or recent epidemiological studies.
  • Look for conflicts of interest or funding sources for Professor Andreas Lopata and the NUH research team.
  • Research the specific allergenic protein profiles of tiger prawns versus vanamei prawns to understand the cross-reactivity claims.
Full transcriptexpand

0:00Unidentified speaker (speaker_0): Best of Live Well, featuring Lance Alexander.

0:05Unidentified speaker (speaker_1): Good morning, Singapore. Now, did you know that shellfish allergy affects an estimated 90,000 to 150,000 people in Singapore? A type of shellfish is the prawn, which turns up in so many of our favorite dishes. Sometimes we don't even see it, but it could be there. From soup stock to some sambal, it may be an ingredient we barely notice. For someone with a prawn allergy, that can make eating pretty tricky. Are we born with a prawn allergy, or can it develop later in life, even after years of eating prawns without a single problem? And could treatment eventually make those everyday decisions easier? NUH recently announced Singapore's first. clinical trial of oral immune therapy for prawn allergy, testing whether gradually increasing doses of specially formulated prawn powder can help patients build tolerance. Researchers are investigating its safety, effectiveness, and whether any benefits last. To tell us more, we have with us a Professor Andreas Lopata, professor in health sciences, tropical futures in Institute at the James Cook University, Singapore. Prof, good morning to you. Welcome to the show.

1:20Unidentified speaker (speaker_2): Good morning.

1:21Unidentified speaker (speaker_1): How do we even develop a prawn allergy? Are we born with it? Or can it happen later in our life after years of eating prawns without a problem?

1:31Unidentified speaker (speaker_2): Yeah, that's a very good question. Uh usually you wouldn't be born. It's not really a genetic disorder. Most allergies not. There is a predisposition. Of course, if both of your parents, for example, have some type of allergy or food allergy, the chance that that a child gets an allergy is much h higher, the likelihood is much higher. But normally uh prone or shellfish allergy develops later in life. Uh we have cases of course where early infants, children under or teenagers have already prone allergy, but usually it develops later on teenager into adulthood. And uh amongst adults, although everybody over twenty years of age, uh the may if anybody the the major food allergy I will say is actually prone or shellfish allergy. Not peanuts and not milk or egg, but among adults is shellfish allergy.

2:20Unidentified speaker (speaker_1): What are some giveaway signs that you have a prone allergy? Uh do you start to scratch? Does your face become swallowed

2:34Unidentified speaker (speaker_2): Exactly. And you need, of course, if you're really uh highly uh al allergic, you need an epi pen or you need a prescription and when you do traveling, when you're at work and school, also children.

2:44Unidentified speaker (UNKNOWN): Uh

2:44Unidentified speaker (speaker_2): but often you have in so called oral allergy syndrome where you start itching in your mouth, you know, uh tingling and you get actually eczema. You're right. Eczema around your body is also a very typical sign of an early anaphylactic uh situation.

2:58Unidentified speaker (speaker_1): Is it immediate or can it be delayed? So after I eat, after I consume some shellfish or some prawns, uh does it happen just like that or maybe in an hour or

3:08Unidentified speaker (UNKNOWN): a

3:08Unidentified speaker (speaker_1): few minutes later? I'm not sure?

3:10Unidentified speaker (speaker_2): It it it's both, both cases. And it that seems to be have to do also with the tissue. So I did my PhD many, many months ago in South Africa. And on abalone allergy. So at the time nobody knew anything about abalone allergy. And most of the patients they were eating in the afternoon or evening for dinner, and then in the middle of the night they woke up with severe problems. So with abalone it seems to be very clear on the and which is the molluscs, also shellfish

3:35Unidentified speaker (UNKNOWN): but

3:35Unidentified speaker (speaker_2): not a crustacean. You have this very long delay and in the it middle of the night suddenly the symptoms occur. But when you talk about prawns, usually it's fairly immediately within the first thirty minutes or an hour.

3:47Unidentified speaker (speaker_1): Okay. So could someone react to one species of prawn but tolerate another? And maybe if you cooked it differently, could someone tolerate it even more so?

3:57Unidentified speaker (speaker_2): Yes. Processing or the cooking, for example, does impact some of the allergens. So we know in in prawns, for example, we know twelve different proteins which are known allergens. They're all registered with the World Health Organization. Some of them were uh identified by us and registered as new allergens in in prawns.

4:15Unidentified speaker (UNKNOWN): But

4:15Unidentified speaker (speaker_2): we did a study and compared five different prawn species.

4:18Unidentified speaker (UNKNOWN): You know, the

4:18Unidentified speaker (speaker_2): tiger prawn, the vanamite prawn, uh the school prawn prone from Australia, and a couple of other prawns, banana prawn is one of them. And

4:26Unidentified speaker (UNKNOWN): they

4:26Unidentified speaker (speaker_2): were there were differences. Yeah, even they're all prawns, they are slight differences, and even some patients make antibodies, which we measure as a biomarker, to some allergens in tiger prone, which you don't see in vanamai. And this is the reason now this immunotherapy we develop with NUHS uh and Dr. Lidia Lydia Wong, we developed this immunother muna therapy for both species. The Vanamai vanamite antigo. and the tiger prone together.

4:52Unidentified speaker (speaker_1): Okay. Uh beyond eating prawns could something in our everyday environment for some reason make our immune system perhaps sensitive to prawn proteins.

5:01Unidentified speaker (speaker_2): Yeah, in general it's immune system. The any allergy, including food allergy is is uh a reaction of the our immune or system against a protein which shouldn't be there. And as you mentioned earlier on you can eat prawns for ten, twenty, thirty years and suddenly develop an allergy. How this trigger is from going from non allergen uh allergenic or allergic to the next one, we don't really know. But of course it's the immune system involved and if your immune system is perhaps weak, there is maybe the likelihood higher that you develop the same as you develop an infection, also maybe easier perceptive to develop some new allergies.

5:40Unidentified speaker (speaker_1): Okay, so if I am allergic to prawns, it means that I'll very likely be allergic to other shellfish too?

5:46Unidentified speaker (speaker_2): Yeah, shellfish uh is again divided into crustaceans and mollusks. So this are all together to cook them together. But when it comes to allergens, they are slightly different. So you can have an allergy to a prawn, and then usually you do cross-react cross react to lobsters and crack. crabs, yeah, uh chili crab and blue swimmer crab. Highly likely, I would say ninety plus percent of patients would cross react. But then also extending it to mussels, abalone

6:14Unidentified speaker (UNKNOWN): uh

6:14Unidentified speaker (speaker_2): and and oysters, for example. This is definitely not necessary given. This has to be really tested out. We don't have many patients there uh allergic to every mollusks and crustaceans. They are There are differences.

6:28Unidentified speaker (speaker_1): Uh are there any newer tests that we can do to improve diagnosis to see whether you're sort of predisposed towards uh a shellfish allergy?

6:37Unidentified speaker (speaker_2): Yeah, the traditional test is uh so-called skin prick test where you have

6:41Unidentified speaker (speaker_1): a

6:41Unidentified speaker (UNKNOWN): little extract on the arm you have to do. Yeah, yeah, because

6:44Unidentified speaker (speaker_1): I'm asthmatic, so they But he

6:45Unidentified speaker (UNKNOWN): want wanted to

6:45Unidentified speaker (speaker_1): see exactly what my problem was. The Yeah,

6:47Unidentified speaker (speaker_2): asthma dustmite, fifty percent of asthma is related to dust. dustmite

6:51Unidentified speaker (UNKNOWN): allergies.

6:52Unidentified speaker (speaker_2): So you can treat this or try to modulate it, manage it better. But you do the same also for food allergy. But then we developed a diagnostic test in the last twenty to thirty years where

7:01Unidentified speaker (UNKNOWN): you

7:02Unidentified speaker (speaker_2): take just a blood sample and then you can test for a couple of hundred different allergens on an diagnostic little device. And the NATO's technology about ten years ago it was developed is called the macro array. Mm-hmm. where you have three hundred allergens. And the other hundred and fifty are really purified single components where we can measure now the IgE antibodies or the markers of allergy in patients against very specific allergens. So we for seafood, fish, shellfish, crustaceans and mollusks, you can test thirty different allergens at the same time. So the speeds up the kind of uh trial out uh and finding out you're allergic to prawn as well as muscles or not? So we can do this now at the same time.

7:50Unidentified speaker (speaker_1): If you see someone who has a very bad reaction to eating shellfish or let's say prawns, what what should you do as a friend, as a colleague, as someone nearby? What's the best thing to do?

8:03Unidentified speaker (speaker_2): Yes, of course. I mean if you know somebody has or has symptoms, I

8:07Unidentified speaker (UNKNOWN): mean uh

8:07Unidentified speaker (speaker_2): it's like with any anaphylaxis, you should uh not move around much, you should lie down, put your feet higher up than your head, like in kind of

8:16Unidentified speaker (speaker_1): why why not move? Is it something that works through your lymph

8:18Unidentified speaker (UNKNOWN): nodes?

8:19Unidentified speaker (speaker_2): You you uh increase the circulation of these antibodies around the body. When you talk about anaphylaxis, you have certain cells then interacting between the antibodies we are making and between the allergen coming into the food. These cells they're starting to get twitchy. And you can have them in your lung, uh in your stomach, or and this is then kind of localized reaction. But if you move a lot around then these uh cell markers which are released, like histamine, you

8:47Unidentified speaker (UNKNOWN): know when you have this

8:48Unidentified speaker (speaker_2): itchiness

8:49Unidentified speaker (UNKNOWN): of the

8:49Unidentified speaker (speaker_2): skin, it can then

8:54Unidentified speaker (speaker_1): Okay, but maybe drinking more water, things like that, could that help

8:59Unidentified speaker (UNKNOWN): stop

8:59Unidentified speaker (speaker_1): the reaction?

9:00Unidentified speaker (UNKNOWN): No.

9:01Unidentified speaker (speaker_2): Yeah, not really.

9:01Unidentified speaker (UNKNOWN): Uh

9:01Unidentified speaker (speaker_2): it's just the time. Okay.

9:03Unidentified speaker (UNKNOWN): So

9:03Unidentified speaker (speaker_2): the time lie down, uh ideally that you're doing cook unconscious, usually it would give away. But afterwards you should definitely see a doctor and then if it's needed, uh get an EpiPen prescription.

9:14Unidentified speaker (speaker_1): I guess the worrying thing is some people may have a prawn reaction, but when they go out and eat, we don't know what exactly goes into the

9:22Unidentified speaker (UNKNOWN): food

9:22Unidentified speaker (speaker_1): preparation and sometimes they may include a bit of prawn paste and that sort of reaction could be pretty bad. And

9:28Unidentified speaker (speaker_2): exactly. So 'cause people always say, Oh, if you have a uh a shellfish allergy then you eat don't eat a prawn.

9:33Unidentified speaker (speaker_1): But

9:34Unidentified speaker (speaker_2): and and that's typical Western uh uh response when you're coming from Germany, Europe or Australia. Sure. It's very easy. But uh as soon as you come to Asia, uh any dish can have some kind of prone paste, as you say, just for the flavorant. That's a half a teaspoonful. And if you have an allergy, this can be often enough to trigger some response.

9:53Unidentified speaker (speaker_1): Hmm. We were hoping to have another professor with us, and that was uh Professor Lydia Wong, who is a consultant immunology and research. rheumatology, Department of Pediatrics, Skute Point National University, Children's Medical Institute at the National University Hospital. But sadly she was called away. So I'm gonna ask you a few other questions, Professor, because you're familiar with her work, with uh Prof. Wong's work. How does oral immune therapy work? And what would a participant actually have to do?

10:26Unidentified speaker (speaker_2): It's a very good question. because uh these oral immunotherapies started already a few years ago with peanut allergy in the US. So there were several studies conducting using also peanut powder. So there's a powder generated from peanuts. Right. You know how much allergens are in there, and they are introduced into capsules or as a powder onto the food. And then uh children or uh patients have to take small amounts every day for several months. And it was quite successful on peanuts. That's why uh Dr. Wong and myself really thought about developing immunotherapy, also the shellfish. So that's one of the few studies we know in the world at all trying to do this, definitely the first one here in Singapore. So they there were using also powder generated from two prone species, so

11:13Unidentified speaker (UNKNOWN): to

11:14Unidentified speaker (speaker_2): avoid that we only uh trigger with certain patients which are uh tiger prone and vanamide prone. We generate powder which sounds easy but it's was very expensive, very difficult to make these powders standardize them. So we measure the amount of allergens which are in there and every batch we are producing. And then these uh patients, the candidates in immunotherapy, have small amounts of this every day over several months. And what happened happens? Their body uh uh develops their own immune response. Okay

11:43Unidentified speaker (UNKNOWN): so

11:43Unidentified speaker (speaker_2): you don't need any more an epipen, yeah, working with accidental exposure or some kind of reaction. But the body makes their own antibodies which are protective. So they will recognize next time you eat a prawn uh to small amounts, it will recognize this and remove these allergens from your blood system so they don't interact with other cells and causing some allergic uh clinical reaction.

12:06Unidentified speaker (speaker_1): Prof, it has to be done obviously in the very control in a very controlled environment because you can't have them take this sort of powder from their uh bedroom or in the kitchen. It has to be done under a medical setting?

12:18Unidentified speaker (speaker_2): Yeah, well uh at the at the beginning we will have an oral food challenge, so the patients will have some uh prawn powder to see how they're reacting. And then the first couple of uh sessions they will take the powder in a controlled setting in a hospital as I said. But afterwards the idea that they can take it home and can do it at home in small amounts and increasing amounts at home. So make it easy for the patients because if you have children, you have to come every day into the clinic. It's

12:44Unidentified speaker (UNKNOWN): very

12:44Unidentified speaker (speaker_2): unpractical.

12:45Unidentified speaker (UNKNOWN): So

12:45Unidentified speaker (speaker_2): Sure. and people will drop out.

12:46Unidentified speaker (speaker_1): Okay, tell us about the success rate as well. Have you had people already on the program? How long have they been on the program and then have they tried their first uh small sample of prawn and found that they did not have a reaction?

12:58Unidentified speaker (speaker_2): Yeah, unfortunately we are very early days.

13:00Unidentified speaker (UNKNOWN): The

13:01Unidentified speaker (speaker_2): only funding cycle started

13:02Unidentified speaker (UNKNOWN): this

13:02Unidentified speaker (speaker_2): year. We got funding from the NIF and then uh NHMRC. So uh

13:08Unidentified speaker (speaker_1): Are you looking

13:09Unidentified speaker (UNKNOWN): for more people?

13:10Unidentified speaker (speaker_1): Oh you are?

13:11Unidentified speaker (speaker_2): We we are have we having already started or although the Dr. Wong sees a very already few patients uh uh which are uh participating in a study. But uh I'm not sure if we need more. That's what's something we would have to speak to Dr. Wong if we need about fifty patients, plus minus, so it's not

13:28Unidentified speaker (UNKNOWN): a large

13:29Unidentified speaker (speaker_2): quantity. And because those so many people are sensitized and

13:33Unidentified speaker (UNKNOWN): allergic to

13:33Unidentified speaker (speaker_2): prone,

13:34Unidentified speaker (speaker_1): it

13:34Unidentified speaker (speaker_2): takes only a few months to get so many patients enrolled.

13:37Unidentified speaker (speaker_1): Sure. Is it easier, would you say, with this powder as well? Um, I'm not sure whether you'll be able to clarify the information without Prof. Wong being here. Is it easier to build resistance if you're younger? Because you

13:49Unidentified speaker (UNKNOWN): think

13:50Unidentified speaker (speaker_1): because you're younger, if

13:51Unidentified speaker (UNKNOWN): you

13:51Unidentified speaker (speaker_1): give them a bit more powder, their body will react and as you as you get older it builds up a natural immune system?

13:59Unidentified speaker (speaker_2): It it's a very good point uh because uh monotherapy therapy is already used for house dustmite allergy, for example, or so dustmite allergy, for over twenty years. And there the data there are thousands of data we know from different studies. It seems to be work better for younger children uh than for older. And the immune system is more reactive. But then we are dealing with an inhalant allergen which is very different from a food allergen. So it's it's really it I think it's probably also patient. dependent, uh and how severe these patients are sensitized. So the severity uh is also different and that's also depending on the antibodies these patients already making against the allergens. So we can kind of quantify this. But I would not generalize this that younger one in general

14:43Unidentified speaker (UNKNOWN): are easier.

14:45Unidentified speaker (speaker_1): Well we you were saying earlier on that uh it's being used already with those with peanut allergies that they're making it into a powdery

14:53Unidentified speaker (UNKNOWN): form.

14:53Unidentified speaker (speaker_1): Could we see it beyond shellfish? Could we see it maybe people who've got a pollen allergy, could they also h end up having it grounded up and and maybe having it sniffed or or different

15:05Unidentified speaker (UNKNOWN): sorts of things that that

15:06Unidentified speaker (speaker_1): that you could apply and then hopefully we see people becoming less and less allergic to certain things that used to trouble them.

15:13Unidentified speaker (speaker_2): Yeah. So as I said with the food we're having a powder

15:16Unidentified speaker (UNKNOWN): which

15:16Unidentified speaker (speaker_2): the the the the participants have to add on their rice or on food. So it's easy to eat and because it's a prawn, uh we tasted it. It's actually tastes quite uh bland, though it's not really strong plant.

15:28Unidentified speaker (UNKNOWN): Yeah of course

15:28Unidentified speaker (speaker_2): we tried it. So that's that's part of the study. If we can't eat it ourselves, we can't give it to children.

15:34Unidentified speaker (speaker_1): Fair enough.

15:35Unidentified speaker (UNKNOWN): Fair

15:35Unidentified speaker (speaker_1): enough.

15:35Unidentified speaker (speaker_2): So yeah, and and when you look at household house osmite smite allergy and pollen, there are already therapeutics out and they're called sublingual. So it's a little drop you put under your tongue and it absorbs under your tongue and the body takes it up. So that's already in place also for pollen. But there is a the c downside of this, most of these therapeutics, especially for pollen, grass and tree pollen, is developed in Europe and

15:59Unidentified speaker (UNKNOWN): the

15:59Unidentified speaker (speaker_2): US. Yeah. And here in Asia we

16:01Unidentified speaker (UNKNOWN): have

16:01Unidentified speaker (speaker_2): different pollens pollen.

16:02Unidentified speaker (UNKNOWN): now.

16:03Unidentified speaker (speaker_2): And again, there is definitely a gap, and you're right. Once we can see we we have a platform how we can develop therapies for local food allergy, we will also be able to do this for local inhalant pollen and grass allergy.

16:16Unidentified speaker (speaker_1): So coming back to this powder for prawns, it is still at a very early stage. How long before we get results? Have you got any idea how long this whole process normally takes before we can say, Okay, we're ready to put it into the market for people to help them?

16:34Unidentified speaker (speaker_2): Yeah. Look with the study gets funded for five years. So by the end of the five years we definitely will have a a go or no go answer for sure.

16:44Unidentified speaker (speaker_1): Yeah.

16:45Unidentified speaker (speaker_2): So we will probably finish with the first kind of round of trials by the end of next year, twenty seven. Sure. And then we have to get patients in later on to see how long they uh are uh desensitized as we call it against the prawns and then can eat small amount of prawns. So it will take about three to four years before we get really good results.

17:06Unidentified speaker (speaker_1): Okay, and if you take it in comparison with people with the peanut allergy, how far ahead are they? Have you noticed or have you seen or have you heard about how successful some of their research has been?

17:18Unidentified speaker (speaker_2): Yeah, they their research, you must think also timescales probably started fifteen years ago. They are the much, much longer ahead from from what we are doing. And they're definitely successful, absolutely. Uh the majority of them staying desensitized for a long time. Uh having said this, there are other kind of therapeutic treatments now in development, also in Australia. Colleagues of mine with egg and milk allergy using, for example, probiotics in addition to the normal food allergen. So giving the whole extract of the food that seems to work quite well. But in combination with other stimulants like probiotics, uh, in this particular case, seems also to be make it even more efficient.

17:57Unidentified speaker (speaker_1): Okay. So with people with this prone prawn allergy and now they're taking the powder. have uh they also tried perhaps different types of shellfish just to see their reaction, whether there's been any adverse reactions to to perhaps other shellfish other

18:14Unidentified speaker (UNKNOWN): than

18:14Unidentified speaker (speaker_1): prawns.

18:21Unidentified speaker (speaker_2): here in Geylang. So we are analyzing uh firstly all the patients uh when they come in, they give a small blood. sample to us. So and then we testing it as basically in the lab. If they are s the type of antibodies they make against prone against the different prawns and we test a whole range of different other shellfish uh without the patient actually have to take and eat it and being at risk of getting anaphylaxis. We will test it basically in the laboratory at JCU and we can say what they're they sensitized at the beginning of the stuff at the study. and then during and at the end of the trial, we will see that we see a desensitization not just to prawn but also to other kind of shellfish and mollusks.

19:00Unidentified speaker (speaker_1): Are you using artificial intelligence in a big way as well? Could artificial intelligence help us find solutions for people who are having all sorts of allergies?

19:09Unidentified speaker (speaker_2): It's a very good question. And in allergy research we are in the early stages, yeah. Uh in cancer it's much more developed. Uh I think there's also more funding in this area. But absolutely, uh we're using a lot of uh biochemical methods where we generate a lot of data like uh mass spectrometry for example,

19:27Unidentified speaker (UNKNOWN): which we

19:27Unidentified speaker (speaker_2): do uh with colleagues in NUS. Uh we are sequencing the different proteins, the allergens. Right. So we have at least twelve allergens which are registered, but there are a few other ones which are not registered yet, but they are relevant in Singapore. We sequence the protein sequence and then we identify where exactly the antibody binds, because sometimes they're very long proteins, but very small amounts of it, like ten or twenty amino acids as we call it, they are responsible for the antibody binding. So because we get so much data out of this, basically uh hundreds of thousands of data points point for every single patient and protein. Uh we will use in a later stage also AI to identify more making sense of the data of the desensitization and sensitization profile to improve diagnostics and the therapy.

20:17Unidentified speaker (speaker_1): Okay, Prof. While the research continues, just a reminder what precautions matter most when eating out for someone who has a a prone allergy? Because I'm talking about stalks, sources, as well as shared cooking utensils.

20:36Unidentified speaker (speaker_2): Mostly happens really when you go out eating. At home you know what you're dealing with. It's uh not easy to to manage. If you really have a severe allergy, you need to have an EpiPen. And to see your allergy specialist here in Singapore, uh, for example Dr. Lydia Wong. Uh then s secondly really asking the waiter, asking what is in the food. Uh there's um uh more and more people are trained in restaurants to know what's in the different dishes and and tell the waiter you have an allergy to a certain food, to milk, to egg, to gluten as we know, but also to shellfish and ask them directly if they can recommend it. Often they go back into the kitchen and talk to the chef. So I think that's a safe way to go. In uh in Australia we do this very frequently. allergy really and and we have a good health system. But often they didn't know. We had a twenty one year old young uh uh woman at a Christmas party had prone dumplings and got anaphylactus right there, didn't know she had a prone allergy, maybe she did never ate it, and on the way in the ambulance sh sh she died. Also these cases still happen

21:53nowadays. It often starts with teenagers where they also have peer pressure to eat stuff, try stuff out, even if you don't feel well and they're uh often not easy to talk to their peers and saying here, I think I have a problem. So discussing this in the family and with friends openly is very important.

22:21Unidentified speaker (speaker_1): Singapore I'm Lance Alexander for MoneyFM 89.3.

22:25Unidentified speaker (speaker_0): For more conversations and podcasts, visit MoneyFM893.sg.

This page was produced automatically: the audio was transcribed with nvidia/parakeet-tdt-0.6b-v3+sortformer-v2.1 and interpreted by Qwen3.6-35B-A3B-UD-IQ3_S.gguf. Transcription and interpretation can contain errors; always confirm against the original episode. Nothing here is investment advice.
All insights